Risk factors for invasive pneumococcal disease

Reviews and Research in Medical Microbiology

Volumn 13, Issue 1, 2002, Pages 29-36

  Schoenmakers, Micha C J ^a   Hament, Jeanne Marie ^a   Fleer, Andre ^a   Aerts, Piet C ^a   Van Dijk, Hans ^a   Kimpen, Jan L L ^a   Wolfs, Tom F W ^a  

^a NONE   (Netherlands)

Author keywords

Invasive pneumococcal disease; Pneumonia; Risk factors; Sepsis; Streptococcus pneumoniae

Indexed keywords

PNEUMOCOCCUS VACCINE;

AGE; ARTICLE; HUMAN; INFECTION PREVENTION; INFECTION RISK; MENINGITIS; MORBIDITY; PRIORITY JOURNAL; RISK FACTOR; SEPSIS; SEX RATIO; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 0036187292     PISSN: 0954139X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00013542-200201000-00003     Document Type: Article

References (78)

1. Pneumococcal bacteremia in Charleston County, South Carolina. A decade later
2. Invasive pneumococcal infections: Incidence, predisposing factors, and prognosis
3. Invasive pneumococcal disease in Dallas County, Texas: Results from population-based surveillance in 1995
4. Streptococcus Pneumoniae
5. Invasive pneumococcal disease in England and Wales: Vaccination implications
6. Streptococcus pneumoniae infections of the female genital tract and in the newborn child
7. Pneumococcal septicemia in the newborn
8. Neonatal Streptococcus pneumoniae infection: Case reports and review of the literature
9. Epidemiological studies of Streptococcus pneumoniae in infants: Antibody to types 3,6,14 and 23 in the first two years of life
10. Dynamics of nasopharyngeal colonization by Streptococcus pneumoniae
11. Nasopharyngeal colonization in Southern Israel with antibiotic-resistant pneumococci during the first 2 years of life: Relation to serotypes likely to be included in pneumococcal conjugate vaccines
12. Nasopharyngeal carriage of antibiotic-resistant pneumococci by children in group day care
13. Risk factors for children for primary invasive pneumococcal disease among children in Finland
14. Risk factors for invasive disease caused by Streptococcus pneumoniae among Alaska native children younger than two years of age
15. A longitudinal study of the nasopharyngeal carriage of pneumococci as related to pneumococcal vaccination in children attending day-care centers
16. The epidemiology of invasive pneumococcal disease in Alaska, 1986-1990 - Ethnic differences and opportunities for prevention
17. Epidemiologic studies of Streptococcus pneumoniae in infants
18. Epidemiologic studies of the first 24 Streptococcus pneumoniae in infants: Acquisition, carriage and infection during the first months of life
19. Respiratory viral infections predisposing for bacterial disease: A concise review
20. Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution and the isolation of respiratory viruses
21. Viral potentiation of bacterial superinfection of the respiratory tract
22. Human milk and host defense: Immediate and long-term effects
23. Anti-endotoxin antibodies in human milk: Correlation with infection of the newborn
24. Cigarette smoking and pneumococcal disease
25. Breastfeeding, maternal smoking and lower respiratory tract infections
26. Urinary cotinine and parent history (questionnaire) as indicators of passive smoking and predicators of lower respiratory illness in infants
27. Ecology of passive smoking by young infants
28. Evaluation of a home-based intervention program to reduce infant passive smoking and lower respiratory illness
29. Environmental tobacco smoke: A hazard to children
30. Absence of antibiotic-resistant streptococcus pneumoniae pharyngeal colonization in Cleveland children with sickle cell disease
31. High prevalence of multidrug-resistant Streptococcus pneumoniae among children in a rural Kentucky community
32. Increasing prevalence of penicillin-resistant pneumococcal infections in children in Southern Israel: Implications for future immunization policies
33. Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: Implications for development of a conjugate vaccine
34. The drug-resistant pneumococcus. Clinical relevance, therapy, and prevention
35. Invasive pneumococcal infections in Canadian Children, 1991-1998: Implications for new vaccination strategies
36. Epidemiology of invasive Streptococcus pneumoniae infections in adults in Finland
37. High incidence of invasive pneumococcal disease in the White Mountain Apache population
38. Prognostic factors for pneumococcal bacteremia in a university hospital
39. Risk factors for acquiring pneumococcal infections
40. Pneumococcal adherence to the buccal epithelial cells of cigarette smokers
41. Effects of race and income on mortality and the use of services among medicare beneficiaries
42. Risk factors for invasive pneumococcal disease in children: A population-based case-control study in North America
43. Epidemiology of invasive pneumococcal disease in Southern California: Implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial
44. Serotypes responsible for invasive Streptococcus pneumoniae among children in Connecticut
45. The burden of pneumococcal disease among adults in developed and developing countries: What is and is not known
46. Invasive pneumococcal disease in central Australia
47. Invasive pneumococcal infections in Baltimore, MD. Implications for immunization policy
48. Emergence of antibody to capsular polysaccharides of Streptococcus pneumoniae during outbreaks of pneumonia: Association with nasopharyngeal colonization
49. Respiratory diseases among U.S. military personnel: Countering emerging threats
50. An epidemic of pneumococcal disease in an overcrowded, inadequately ventilated jail
51. Outbreak of invasive pneumococcal disease in a jail - Texas 1989
52. An outbreak of pneumococcal pneumonia in two men's shelters
53. An outbreak of Streptococcus pneumoniae serotype 1 in a closed community in Southern Israel
54. Epidemiology of pneumococcal infections in the elderly
55. Pneumococcal infections and vaccination in the elderly
56. An outbreak of multidrug-resistant pneumococcal pneumoniae and bacteremia among unvaccinated nursing home residents
57. Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities
58. Pneumococcal soft-tissue infections: Possible association with connective tissue diseases
59. Invasive soft tissue infections with Streptococcus pneumoniae in patients with systemic lupus erythromatosus
60. Unusual manifestations of invasive pneumococcal infections
61. Pulmonary complications of the acquired immunodeficiency syndrome
62. Pulmonary infectious complications of human immunodeficiency virus infection
63. The causes of death in patients with human immunodeficiency virus infection: A clinical and pathologic study with emphasis on the role of pulmonary diseases
64. Bacterial pneumonia in persons infected with the human immunodeficiency virus
65. Streptococcus pneumoniae colonization, bacteremia, and immune response among persons with human immunodeficiency virus infection
66. Pneumococcal bacteremia in patients with neoplastic diseases
67. Infections complicating multiple myeloma and chronic lymphocytic leukemia
68. Rapidly fatal pneumococcal septicemia in systemic lupus erythematosus
69. Opsonic requirements for intravascular clearance after splenectomy
70. Host defense against Streptococcus pneumoniae: The role of the spleen
71. Postsplenenctomy infections
72. Continued need for pneumococcal prophylaxis after splenectomy
73. Overwhelming infection in asplenic patients: Current best practice preventive measures are not being followed
74. Problems of bacterial infection in patients with liver disease
75. Bacterial infections in chronic obstructive pulmonary disease
76. Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease
77. Continuing controversy: Pneumococcal vaccine and COPD
78. Infections in patients with diabetes mellitus